Previous close | 13.60 |
Open | 13.60 |
Bid | 14.30 |
Ask | 14.80 |
Strike | 285.00 |
Expiry date | 2023-04-21 |
Day's range | 13.60 - 13.60 |
Contract range | N/A |
Volume | |
Open interest | 816 |
The bear market crushed many top healthcare stocks -- from young high-growth players to long-established companies generating billions of dollars in earnings. Vertex is the worldwide leader in the cystic fibrosis (CF) treatment market. In fact, last year product revenue climbed 18% to more than $8.9 billion.
Biogen Inc. (BIIB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biogen's (BIIB) sales in the fourth quarter are likely to have been hurt by lower sales of Tecfidera and Spinraza.